Clinical Trial Results:
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging Study Evaluating the Efficacy and Safety of CNTO 148 Administered Subcutaneously in Symptomatic Subjects With Severe Persistent Asthma
Summary
|
|
EudraCT number |
2004-000046-21 |
Trial protocol |
HU CZ SE GB IT |
Global completion date |
17 Jul 2007
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
08 Jun 2016
|
First version publication date |
08 Jun 2016
|
Other versions |
|
Summary report(s) |
C0524T03_2004-000046-21_(Golimumab)_CT.Gov Results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.